OCI PARTNERS LP Filed by OCI N.V.

Similar documents
OAKTREE CAPITAL GROUP, LLC Filed by JMB CAPITAL PARTNERS MASTER FUND L.P.

GOPHER PROTOCOL INC. Filed by FLEMING STEPHEN M.

INTERNATIONAL WIRE GROUP INC Filed by BLACKSTONE DISTRESSED SECURITIES ADVISORS LP

STRAIGHT PATH COMMUNICATIONS INC. Filed by MILLER LLOYD I III

CASTLE BRANDS INC Filed by CAMULOS CAPITAL LP

CENTERPOINT ENERGY INC Filed by VANGUARD GROUP INC

National American University Holdings, Inc.

LEGACY RESERVES LP Filed by BROTHERS PRODUCTION COMPANY, INC.

PRINCIPAL FINANCIAL GROUP INC Filed by CAPITAL RESEARCH GLOBAL INVESTORS

FORBES ENERGY SERVICES LTD. Filed by WEST FACE CAPITAL INC.

ZYNGA INC Filed by CAPITAL RESEARCH GLOBAL INVESTORS

WASTE MANAGEMENT INC Filed by VANGUARD GROUP INC

GLOBUS MEDICAL INC Filed by PAUL DAVID C

Cocrystal Pharma, Inc. (Name of Issuer)

SCHEDULE 13G. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C Under the Securities Exchange Act of (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

VOXELJET AG Filed by TECHNOLOGIE BETEILIGUNGSFONDS BAYERN GMBH & CO. KG

PURE BIOSCIENCE, INC. Filed by OKUNO DALE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D (Rule 13d-101)

LEGACY RESERVES LP Filed by MORIAH PROPERTIES, LTD.

NICE SYSTEMS LTD Filed by PSAGOT INVESTMENT HOUSE LTD.

AON PLC Filed by CAPITAL RESEARCH & MANAGEMENT CO

NELNET INC Filed by CEDAR HILL CAPITAL PARTNERS, LLC

UNITED THERAPEUTICS CORP Filed by SHUMWAY CAPITAL PARTNERS LLC

NEWS CORP Filed by SAUD H R H PRINCE ALWALEED BIN TALAL BIN ABDULAZIZ AL

ROCKWELL COLLINS INC Filed by VANGUARD GROUP INC

SECURITIES AND EXCHANGE COMMISSION FORM SC 13G. Filing Date: SEC Accession No (HTML Version on secdatabase.

NEVADA GOLD & CASINOS INC Filed by HABERKORN STEPHEN J

COMCAST CORP Filed by MICROSOFT CORP

ACCESS INTEGRATED TECHNOLOGIES INC

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

SECURITIES & EXCHANGE COMMISSION EDGAR FILING. Support.com, Inc. Form: SC 13G/A. Date Filed:

SECURITIES AND EXCHANGE COMMISSION. Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934

AMBOW EDUCATION HOLDING LTD. Filed by GIC PRIVATE LTD

Realogy Holdings Corp. (Name of Issuer)

SECURITIES & EXCHANGE COMMISSION EDGAR FILING. HCI Group, Inc. Form: SC 13G/A. Date Filed:

GENCO SHIPPING & TRADING LTD Filed by OZ MANAGEMENT LP

EATON CORP PLC Filed by WELLINGTON MANAGEMENT CO LLP

SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)

ST JOE CO Filed by THIRD AVENUE MANAGEMENT LLC

HAWK SYSTEMS, INC. Filed by GREYSTONE BUSINESS CREDIT II, L.L.C.

Tallgrass Energy Partners, LP (Name of Issuer)

Netlist, Inc. (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

Securities and Exchange Commission. Washington, D.C Schedule 13G. Under the Securities Exchange Act of (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934

VERISIGN INC/CA Filed by LONE PINE CAPITAL LLC

PREFERRED APARTMENT COMMUNITIES INC Filed by WILLIAMS OPPORTUNITY FUND LLC

SCHEDULE 13G* (Rule 13d-102) Corbus Pharmaceuticals Holdings, Inc. (Name of Issuer)

SECURITIES AND EXCHANGE COMMISSION SCHEDULE 13G/A

HASBRO INC Filed by CAPITAL GROUP COMPANIES INC

LEAR CORP Filed by MERRILL LYNCH PIERCE FENNER & SMITH INC

STRAYER EDUCATION INC Filed by AXA FINANCIAL INC

Twilio, Inc. (Name of Issuer)

Section 1: SC 13G/A (SC 13G/A)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C Schedule 13G. Under the Securities Exchange Act of 1934 (Amendment No.

KINGSTONE COMPANIES, INC.

XILINX INC Filed by VANGUARD GROUP INC

EXFO INC. FORM SC 13G/A. (Amended Statement of Ownership) Filed 01/19/12

MEDICAL TRANSCRIPTION BILLING, CORP Filed by OMNI MEDICAL BILLING SERVICES, LLC

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

Main Street Capital Corp.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Under the Securities Exchange Act of 1934 (Amendment No.

American Midstream Partners, LP (Name of Issuer)

Tallgrass Energy GP, LP (Name of Issuer)

UNITED STATES SECURITIES EXCHANGE COMMISSION Washington, D.C

BARRETT BUSINESS SERVICES, INC. (Name of Issuer) Common Stock (Title of Class of Securities) (CUSIP Number)

SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Under the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G (Rule 13d-102)

FEDERAL DEPOSIT INSURANCE CORPORATION WASHINGTON, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

Taubman Centers, Inc. (Name of Issuer)

ECO-STIM ENERGY SOLUTIONS, INC. (Name of Issuer)

DIAMOND RESORTS INTERNATIONAL, INC. Filed by GUGGENHEIM CAPITAL LLC

SCHEDULE 13G (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

Realogy Holdings Corp.

PENN VIRGINIA CORPORATION (Name of Issuer)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

Silvercrest Asset Management Group Inc. (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

Floor & Décor Holdings, Inc. (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G (RULE 13d - 102)

<SEQUENCE>1 <FILENAME>cpst_sc13g.txt. SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G

SECURITIES AND EXCHANGE COMMISSION. Washington, D.C Schedule 13G. Under the Securities Exchange Act of (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A Amendment No. 3. Under the Securities Exchange Act of 1934

SUNOPTA INC. Filed by GRUBER & MCBAINE CAPITAL MANAGEMENT LLC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G (RULE 13d - 102)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D (Rule 13d-101)

3M CO Filed by BLACKROCK INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. REVOLUTION LIGHTING TECHNOLOGIES (Name of Issuer)

Transcription:

OCI PARTNERS LP Filed by OCI N.V. FORM SC 13G (Statement of Ownership) Filed 02/14/14 Address P. O. BOX 1647 NEDERLAND, TX, 77627 Telephone 409-723-1900 CIK 0001578932 Industry Agricultural Chemicals Sector Basic Materials Fiscal Year 12/31 http://www.edgar-online.com Copyright 2018, EDGAR Online, a division of Donnelley Financial Solutions. All Rights Reserved. Distribution and use of this document restricted under EDGAR Online, a division of Donnelley Financial Solutions, Terms of Use.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 OCI Partners LP (Name of Issuer) Common units representing limited partner interests (Title of Class of Securities) 67091N108 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 ( Act ) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13G CUSIP No. 67091N108 (1) Names of reporting persons. OCI N.V. (2) Check the appropriate box if a member of a group (see instructions) (a) (b) (3) SEC use only (4) Citizenship or place of organization Number of common units beneficially owned by each reporting person with: The Netherlands (5) Sole voting power None (6) Shared voting power (7) Sole dispositive power None (8) Shared dispositive power (9) Aggregate amount beneficially owned by each reporting person (10) Check if the aggregate amount in Row (9) excludes certain common units (see instructions) (11) Percent of class represented by amount in Row (9) 78.3% (b) (12) Type of reporting person (see instructions) OO (public limited liability company) (a) (b) Includes 63,000,000 common units representing limited partner interests ( Common Units ) in OCI Partners LP (the Issuer ) held directly by OCI USA Inc. ( OCI USA ). OCI USA is a wholly owned subsidiary of Iapetus B.V. ( Iapetus ). Iapetus is a wholly owned subsidiary of OCI Fertilizer International B.V. ( OCI Fertilizer International ). OCI Fertilizer International is a wholly owned subsidiary of OCI Fertilizers B.V. ( OCI Fertilizers ). OCI Fertilizers is a wholly owned subsidiary of OCI N.V. ( OCI ). Accordingly, each of OCI, OCI Fertilizers, OCI Fertilizer International and Iapetus may be deemed to indirectly beneficially own the Common Units directly held by OCI USA, but each disclaims beneficial ownership, except to the extent of its pecuniary interest therein. Based upon 80,500,000 Common Units outstanding as of November 4, 2013, as reported in the Issuer s most recent Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission on November 18, 2013. 2

SCHEDULE 13G CUSIP No. 67091N108 (1) Names of reporting persons. OCI USA Inc. (2) Check the appropriate box if a member of a group (see instructions) (a) (b) (3) SEC use only (4) Citizenship or place of organization Number of common units beneficially owned by each reporting person with: Delaware (5) Sole voting power None (6) Shared voting power (7) Sole dispositive power None (8) Shared dispositive power (9) Aggregate amount beneficially owned by each reporting person (10) Check if the aggregate amount in Row (9) excludes certain common units (see instructions) (11) Percent of class represented by amount in Row (9) 78.3% (b) (12) Type of reporting person (see instructions) CO (a) (b) Includes 63,000,000 common units representing limited partner interests ( Common Units ) in OCI Partners LP (the Issuer ) held directly by OCI USA Inc. ( OCI USA ). OCI USA is a wholly owned subsidiary of Iapetus B.V. ( Iapetus ). Iapetus is a wholly owned subsidiary of OCI Fertilizer International B.V. ( OCI Fertilizer International ). OCI Fertilizer International is a wholly owned subsidiary of OCI Fertilizers B.V. ( OCI Fertilizers ). OCI Fertilizers is a wholly owned subsidiary of OCI N.V. ( OCI ). Accordingly, each of OCI, OCI Fertilizers, OCI Fertilizer International and Iapetus may be deemed to indirectly beneficially own the Common Units directly held by OCI USA, but each disclaims beneficial ownership, except to the extent of its pecuniary interest therein. Based upon 80,500,000 Common Units outstanding as of November 4, 2013, as reported in the Issuer s most recent Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission on November 18, 2013. 3

CUSIP No.: 67091N108 SCHEDULE 13G Item 1(a) Item 1(b) Item 2(a) Item 2(b) Name of Issuer: OCI Partners LP Address of Issuer s Principal Executive Offices: 5470 N. Twin City Highway Nederland, Texas 77627 Name of Person(s) Filing: OCI N.V. ( OCI ) OCI USA Inc. ( OCI USA ) Address or Principal Business Office or, if none, Residence: Principal business office for OCI: Mijnweg 1 6167 AC Geleen The Netherlands Principal business office for OCI USA: 660 Madison Avenue, 19 th Floor New York, New York 10065 Item 2(c) Citizenship: OCI OCI USA The Netherlands Delaware Item 2(d) Title of Class of Securities: Common units representing limited partner interests ( Common Units ) Item 2(e) CUSIP Number: 67091N108 Item 3 If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a : 4

CUSIP No.: 67091N108 SCHEDULE 13G Item 4 Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. OCI OCI USA (a) Amount beneficially owned: (b) Percent of class: 78.3% (b) 78.3% (b) (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: None None (ii) Shared power to vote or to direct the vote: (iii) Sole power to dispose or to direct the disposition of: None None (iv) Shared power to dispose or to direct the disposition of: (a) (b) Includes 63,000,000 Common Units in OCI Partners LP (the Issuer ) held directly by OCI USA. OCI USA is a wholly owned subsidiary of Iapetus B.V., a Netherlands private limited liability company ( Iapetus ). Iapetus is a wholly owned subsidiary of OCI Fertilizer International B.V., a Netherlands private limited liability company ( OCI Fertilizer International ). OCI Fertilizer International is a wholly owned subsidiary of OCI Fertilizers B.V., a Netherlands private limited liability company ( OCI Fertilizers ). OCI Fertilizers is a wholly owned subsidiary of OCI. Accordingly, each of OCI, OCI Fertilizers, OCI Fertilizer International and Iapetus may be deemed to indirectly beneficially own the Common Units directly held by OCI USA, but each disclaims beneficial ownership, except to the extent of its pecuniary interest therein. Based upon 80,500,000 Common Units outstanding as of November 4, 2013, as reported in the Issuer s most recent Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission on November 18, 2013. Item 5 Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: Item 6 Item 7 Item 8 Item 9 Item 10 Ownership of More than Five Percent on Behalf of Another Person Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person Identification and Classification of Members of the Group Notice of Dissolution of Group Certification 5

SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 14, 2014 Signature Page to Schedule 13G OCI N.V. By: /s/ Nassef Sawiris Nassef Sawiris Chief Executive Officer OCI USA Inc. By: /s/ Kevin Struve Kevin Struve President

JOINT FILING AGREEMENT In accordance with Rule 13(d)-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with each other of the attached statement on Schedule 13G and to all amendments to such statement. IN WITNESS WHEREOF, the undersigned have executed this Joint Filing Agreement as of February 14, 2014. OCI N.V. By: /s/ Nassef Sawiris Nassef Sawiris Chief Executive Officer OCI USA Inc. By: /s/ Kevin Struve Kevin Struve President